brenzavvy

Generic: bexagliflozin

Labeler: theracosbio, llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name brenzavvy
Generic Name bexagliflozin
Labeler theracosbio, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

bexagliflozin 20 mg/1

Manufacturer
TheracosBio, LLC

Identifiers & Regulatory

Product NDC 82381-2174
Product ID 82381-2174_057c1420-60f7-4a86-922c-44b37df317f6
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA214373
Listing Expiration 2026-12-31
Marketing Start 2023-07-13

Pharmacologic Class

Established (EPC)
sodium-glucose cotransporter 2 inhibitor [epc]
Mechanism of Action
sodium-glucose transporter 2 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 823812174
Hyphenated Format 82381-2174

Supplemental Identifiers

RxCUI
2637859 2637865
UNII
EY00JF42FV
NUI
N0000187059 N0000187058

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name brenzavvy (source: ndc)
Generic Name bexagliflozin (source: ndc)
Application Number NDA214373 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 20 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE (82381-2174-1)
  • 90 TABLET in 1 BOTTLE (82381-2174-2)
source: ndc

Packages (2)

82381-2174-1 30 TABLET in 1 BOTTLE (82381-2174-1) 82381-2174-2 90 TABLET in 1 BOTTLE (82381-2174-2)

Ingredients (1)

bexagliflozin (20 mg/1)

Linked Drug Pages (1)

BRENZAVVY ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "057c1420-60f7-4a86-922c-44b37df317f6", "openfda": {"nui": ["N0000187059", "N0000187058"], "unii": ["EY00JF42FV"], "rxcui": ["2637859", "2637865"], "spl_set_id": ["3cdf28fc-4194-4ad6-aa03-c9eaa68da83e"], "pharm_class_epc": ["Sodium-Glucose Cotransporter 2 Inhibitor [EPC]"], "pharm_class_moa": ["Sodium-Glucose Transporter 2 Inhibitors [MoA]"], "manufacturer_name": ["TheracosBio, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (82381-2174-1)", "package_ndc": "82381-2174-1", "marketing_start_date": "20230713"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (82381-2174-2)", "package_ndc": "82381-2174-2", "marketing_start_date": "20230713"}], "brand_name": "BRENZAVVY", "product_id": "82381-2174_057c1420-60f7-4a86-922c-44b37df317f6", "dosage_form": "TABLET", "pharm_class": ["Sodium-Glucose Cotransporter 2 Inhibitor [EPC]", "Sodium-Glucose Transporter 2 Inhibitors [MoA]"], "product_ndc": "82381-2174", "generic_name": "Bexagliflozin", "labeler_name": "TheracosBio, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BRENZAVVY", "active_ingredients": [{"name": "BEXAGLIFLOZIN", "strength": "20 mg/1"}], "application_number": "NDA214373", "marketing_category": "NDA", "marketing_start_date": "20230713", "listing_expiration_date": "20261231"}